APA (7th ed.) Citation

Raimondi, L., Pietranera, M., & Spinelli, G. (2020). 335P Resistance to CDK4/6 inhibitors: Clinical practice use of liquid biopsy to identify KRAS-mutations in ctDNA and overexpression of CDK9 in plasma derived exosomes. Annals of Oncology, 31, S380. https://doi.org/10.1016/j.annonc.2020.08.437

Chicago Style (17th ed.) Citation

Raimondi, L., M. Pietranera, and G.P Spinelli. "335P Resistance to CDK4/6 Inhibitors: Clinical Practice Use of Liquid Biopsy to Identify KRAS-mutations in CtDNA and Overexpression of CDK9 in Plasma Derived Exosomes." Annals of Oncology 31 (2020): S380. https://doi.org/10.1016/j.annonc.2020.08.437.

MLA (9th ed.) Citation

Raimondi, L., et al. "335P Resistance to CDK4/6 Inhibitors: Clinical Practice Use of Liquid Biopsy to Identify KRAS-mutations in CtDNA and Overexpression of CDK9 in Plasma Derived Exosomes." Annals of Oncology, vol. 31, 2020, p. S380, https://doi.org/10.1016/j.annonc.2020.08.437.